Skip to main content
. 2019 Feb 19;19(6):1–199.

Table 5:

Results of Economic Literature Review—Cost-Effectiveness of iCBT in the Treatment of Anxiety Disorders

Name, Year, Location Methods Results
Study Design and Perspective Population Interventions/Comparators Health Outcomes Costs Cost-Effectiveness
Kumar et al, 2018,63 United States
  • Cost–utility analysis

  • Decision analytic (modeling) analysis

  • Health care payer perspective and societal perspective

  • Time horizon: lifetime

  • Discount rate: 3%

  • Adults with GAD with or without comorbidities (GAD-7 scores: 5–9 (mild), 10–14 (moderate), 15–21 (severe)

  • Mean age (overall): NR

  • Female (overall): NR

  • Modeled: Markov model, 3-mo cycle length, 8 health states (no anxiety, mild, moderate/severe anxiety without/with comorbidities [4 separate states], death); health state utilities linearly extrapolated from SF-6D scores elicited in adults with GAD, non-specific to CBT; extrapolation of 3-mo treatment effects over 5 yr, assuming a gradual decrease of the lifetime; risk of suicide independent of treatments associated with major depression, based on literature and modeled in the states combined with comorbidities

  • Intervention: coach-guided iCBT, “Lantern”: 1) prevention (all patients starting with mild anxiety (GAD-7: 5–9); 2) treatment (patients starting with moderate or severe anxiety, GAD-7: >10–21), 3) both prevention and treatment

  • Comparators: 1) TAU: pharmacotherapy (58.6% of the cohort) or nothing; 2) face-to-face CBT (12–20 1-hr sessions)

  • iCBT: 3-mo program with 8 CBT modules accessible over the mobile application, support provided by a trained coach via asynchronous messages; pilot test included 89 employees; iCBT program assumed equivalent to face-to-face CBT

  • Total QALYs (per 100,000), iCBT vs. face-to-face CBT vs. TAU: NR

  • Mean difference, iCBT vs. face-to-face CBT/iCBT vs. TAU for 3 scenarios: 1) base case (both): 34,108/81,492 QALYs; 2) prevention only: 28,959/76,568 QALYs; 3) treatment only: 36,564/83,841 QALYs

  • Currency: USD Year: 2016

  • Total costs (mean per 100,000, in billion $), iCBT vs. face-to-face CBT vs. TAU: 1) payer perspective, both/prevention/treatm ent: 24.9 vs. 25.3 vs. 25.5/24.9 vs. 25.2 vs. 25.4/24.9 vs. 25.3 vs. 25.6; 2) societal perspective, both/prevention/treatm ent: 36.5 vs. 38.7 vs. 41.0/36.3 vs. 38.2 vs. 40.4/36.6 vs. 38.9 vs. 41.3

  • Mean difference (per 100,000, in billion $), iCBT vs. face-to-face CBT, and iCBT vs. TAU: 1) payer perspective, both/prevention/treatm ent: a) 339/297/360; b) 605/553/630; 2) societal perspective, both/prevention/treatm ent: a) 339/297/360; b) 605/553/630

  • Base-case analysis, iCBT compared with face-to-face CBT or TAU (pharmacotherapy alone), payer or societal perspective: cost saving (higher benefits, lower costs)

  • Sensitivity analysis: PSA not conducted; a single deterministic sensitivity analysis showed that face-to-face CBT became as cost-effective as iCBT when clinical response rate in face-to-face CBT increased to 76% (from 42% in base case analysis), while cost-effectiveness remained the same for iCBT (38%)

El Alaoui et al, 2017,61 Sweden
  • Individual-level cost-minimisation analysis, continues previous RCT by Hedman et al (2014)

  • Noninferiority RCT, 4-yr follow-up

  • Health care payer perspective

  • Time horizon: 15 wk (treatment cycle)

  • Discount rate: 0%, 3%, 5%

  • Adults with SAD (N = 126)

  • Mean age: NR

  • Female: NR

  • Intervention: guided iCBT modules including homework exercises (n = 64)

  • Comparator: face-to-face group CBT (n = 62)

  • iCBT: online modules, 15 wk, with access to a therapist and supportive email feedback (time spent with a patient: 10 min/wk)

  • Group iCBT: 15 sessions, 1 individual and 14 weekly group CBT sessions, 2.5 hr long, groups of 5–7 patients, led by CBT-trained therapists

  • Total QALYs (mean per person), iCBT vs. group face-to-face CBT: NA (equivalence in effects confirmed in prior RCT)

  • Mean difference: NA

  • Currency: € Year: 2017

  • Total costs and resource use (mean), iCBT vs. group CBT, 80% capacity (base case): 463 (446–480) vs. 806 (730–883)

  • Mean difference, at 80% capacity: −343 (–267 to −420)

  • Resource use estimated using a bottom-up approach, costing clinical and administrative activities during the treatment delivery cycle

  • Base-case analysis, the cost-minimization analysis, at 80%, 50%, or 100% capacity: iCBT cost saving in all analyses

Hedman et al, 2016,60 Sweden
  • Individual-level cost-effectiveness and cost–utility analysis

  • RCT

  • Societal perspective

  • Time horizon: 12 wk

  • Discount rate: 0%

  • Adults with severe lasting health anxiety (hypochondriasis), primary care setting (N = 158)

  • Mean age, iCBT vs. control: 41.7 (SD: 13.6) vs. 41.4 (SD: 13.2) yr

  • Females, iCBT vs. control: 81% vs. 77%

  • Anxiety present for around 13 yr

  • Intervention: iCBT modules including homework exercises (n = 79)

  • Comparator: Control internet delivered behavioural stress management program (n = 79)

  • iCBT: 12 modules over 12 wk, with access to a therapist via a secure online contact system

  • Total QALYs (mean per person), iCBT vs. control, post-treatment: NR

  • Mean difference: 0.031

  • Currency: USD Year: 2013

  • Total costs (mean), iCBT vs. control, post-treatment: 1,607 (SD: 1,698) vs. 1,340 (SD:1,123)

  • Mean difference: 310

  • Cost of treatment: 571 vs. 431

  • ICER of base-case analysis: $10,000 per QALY

  • Probability of iCBT being cost-effective compared with control at a wtp per QALY: NR

Dear et al, 2015,62 Australia
  • Individual-level cost-effectiveness analysis

  • Open RCT

  • Australia, health sector perspective

  • Time horizon: 2 mo

  • Discount rate: 0%

  • Adults aged 60 yr or older with anxiety (GAD-7 ≥8), residents of Australia (N = 72)

  • Mean age, intervention vs. control: 65.4 (SD: 4.7) vs. 65.5 (SD: 5.8) yr

  • Females, intervention vs. control: 67% vs. 54%

  • With previous mental health treatment, intervention vs. control: 54% vs. 49%; taking medications: 24% vs. 38%

  • Intervention: supported iCBT program “Managing Stress and Anxiety Course” (n = 75)

  • Comparator: TAU: Usual GP care (n = 64)

  • iCBT supported by a clinical psychologist via email or phone on weekly basis; iCBT consisted of 5 lessons delivered over 8 wk

  • Outcomes: QALYs and costs; iCBT costs included therapist's time, supervisors's time (1-hr supervision weekly), internet access, computer and telephone use but not cost of software; other health care resource use: medications, GP and psychiatric consultations, and admissions

  • Total QALYs (mean per person), iCBT vs. control: 0.102 (0.044–0.139) vs. 0.092 (0.033–0.128)

  • Mean difference: 0.01 (0.003–0.018)

  • Currency: USD Year: 2013

  • Total costs (mean), iCBT vs. control: 229.5 (184.9–276.4) vs. 137.4 (98.4–173.5)

  • Mean difference: 92.2 (38.7–149.2)

  • Costs of guided iCBT associated per patient: £42

  • ICER for base-case analysis: $8,806 per QALY

  • Probability of iCBT being cost-effective compared with control at wtp of $50,000 per QALY: >95%

Nordgren et al, 2014,56 Sweden
  • Individual-level cost-effectiveness and cost–utility analysis

  • Open RCT

  • Sweden, societal perspective

  • Time horizon: 10 wk

  • Discount rate: 0%

  • Adults with an anxiety disorder by DSM-IV with or without comorbid problems, primary care setting (N = 100)

  • Mean age, iCBT vs. control: 35 (SD:13) vs. 36 (SD:12) yr

  • Females, iCBT vs. control: 33% vs. 30%

  • Prior psychotherapy: 66%–68%, ongoing medication: 24%–28%, most commonly diagnosed with GAD or panic disorder (64%), 56%–60% with any comorbidity

  • Intervention: guided iCBT, individually tailored (n = 50)

  • Comparator: TAU for 10 wk, allowed cross-over after 10 wk (n =50)

  • iCBT: 10 modules with homework, delivered weekly over 10 wk, supported by a therapist via internet messenger system, support provided within 24 hr and feedback on homework (≤15 min/wk per client), cost per client: $507

  • TAU: weekly email from a therapist related to well-being, no specific feedback (unless the therapist judged the further action was required), cost per client: $68

  • Total QALYs (mean per person by EQ-5D), iCBT vs. control: NR

  • Mean difference: 0.063

  • Currency: USD Year: NR

  • Total costs (mean), iCBT vs. control, pretreatment/post-treatment: $2,648 (SD: 1,812)/$1,757 (SD: 1,870) vs. $1,803 (SD:1,694)/$2,078 (SD:1,868)

  • Mean difference: −$474

  • Significant time-group interaction: iCBT group had larger indirect cost reduction vs. control

  • Base-case analysis, iCBT vs. TAU, ICER: −$7,523 per QALY; cost saving and more effective

  • Probability of iCBT being cost-effective compared with control at wtp of $0 per QALY was 90%, rising above 95% at $3,000/QALY

  • Sensitivity analysis: if iCBT increased by $600, probability of iCBT being cost-effective compared with control at wtp of $0 per QALY was 37% and was 60% at $3,500/QALY

Hedman et al, 2014,59 Sweden
  • Individual-level cost-effectiveness and cost–utility analysis

  • Noninferiority parallel-group RCT, 4-yr follow-up

  • Societal perspective

  • Time horizon: 4 yr (mean: 4.2, range: 3.1–5.3 yr)

  • Discount rate: NR (0%)

  • Adults with SAD (N = 126)

  • Mean age, iCBT vs. group CBT: 35.2 (SD:11.2) vs. 35.5 (SD: 11.6) yr

  • Females, iCBT vs. control: 37.5% vs. 33.9%

  • Anxiety present for around 20 yr, 16% with comorbid major depression; 34% of patients in iCBT and 38% of patients in group CBT received additional treatment (CBT, psychological treatment, or medication) after finalizing the intervention in year 1

  • Intervention: guided iCBT modules including homework exercises (n = 64)

  • Comparator: face-to-face group CBT (n = 62)

  • iCBT: online modules, 15 wk, with access to a therapist (psychologist) and supportive email feedback via text-based messaging system with no phone/face-to-face contact; on average 9 of 15 modules completed, cost per treated patient: $464

  • Group iCBT: 15 sessions, 1 individual and 14 weekly group CBT sessions including homework between sessions, 2.5 hr long, groups of 6–7 patients, led by CBT-trained experienced psychotherapists; on average 9 of 15 sessions completed, cost per treated patient: $2,687

  • Total QALYs (mean), iCBT vs. group CBT, within group before intervention to 4-yr follow-up: −0.36 (–0.70 to −0.01) vs. −0.25 (–0.60 to 0.10)

  • Mean difference, iCBT vs. group CBT: 0.11

  • Total QALYs (mean), iCBT vs. group CBT, between group before 4-yr follow-up: −0.18 (–0.53 to 0.17)

  • No significant interaction of group and time

  • Currency: USD Year: NR

  • Total costs (mean), iCBT vs. group CBT, before and at 4-yr follow-up: before treatment, 14,096 (SD: 14,952) vs. 15,546 (SD: 15,852); after 4 yr, 6,349 (SD: 8,366) vs. 8,532 (SD: 7,464)

  • Mean difference: −808

  • Base-case analysis, iCBT vs. group CBT, ICER: −$7,345 per QALY; cost saving and more effective

  • Probability of iCBT being cost-effective compared with group CBT at wtp of $0 per QALY is 62% and at wtp of $100,000 per QALY is 64%

Hedman et al, 2013,57 Sweden
  • Individual-level cost-effectiveness and cost–utility analysis

  • RCT

  • Societal perspective

  • Time horizon: 1 yr

  • Discount rate: 0%

  • Adults with severe lasting health anxiety and no history of psychosis/bipolar disorder (N = 81)

  • Mean age, iCBT vs. control: 39.3 (SD:9.8) vs. 38.8 (SD: 9.5) yr

  • Females, iCBT vs. control: 70% vs. 78%

  • Anxiety present for around 20 yr

  • Intervention: iCBT modules including homework exercises (n = 40)

  • Comparator: Online discussion forum (n = 41)

  • iCBT: 12 modules of sessions taken over 12 wk, with access to a therapist via a secure online contact system (time spent with a patient: 9 min/wk): cost of treatment £210

  • Total QALYs (mean per person), iCBT vs. control: NR

  • Mean difference: 0.12

  • Currency: £ Year: 2010

  • Total costs (mean), iCBT vs. control: NR

  • Mean difference: −784

  • Base-case analysis: ICER: £-6533 per QALY; cost saving

  • Probability of iCBT being cost-effective compared with control at wtp of £5,000 per QALY: 77%

National Collaborating Centre for Mental Health and NICE, 2013,64 United Kingdom
  • Cost–utility analysis

  • Model-based analysis

  • NHS and PSS perspective

  • Time horizon: 12 wk of intervention plus 5 yr of follow-up

  • Discount rate: NR

  • Adults with social anxiety disorder (1.5% of all anxiety disorders)

  • Mean age: NR

  • Females: NR

  • Hybrid decision tree: Markov model compared 28 interventions including drugs and iCBT; utilities: 0.866 associated with recovery and 0.659 with non-recovery, relapse

  • Interventions: guided and unguided iCBT

  • Comparators: waitlist control, drug (sertraline), placebo

  • Total QALYs (mean per 1000 persons), iCBT vs. control: 1) guided: 3,540; 2) unguided iCBT: 3,848; 3) drug: 3,490; 4) waiting list: 3,366; 5) placebo: 3,401

  • Mean difference: NR

  • Currency: £ Year: 2012

  • Total costs (mean), iCBT vs. control: 1) guided: 4.87 million; 2) unguided iCBT: 4.74 million; 3) drug: 4.27 million; 4) waiting list: 4.29 million; 5) placebo: 4.396 million

  • Mean difference: NR

  • Total costs of iCBT/drug include costs of visits to GP: 1 for iCBT and 7 for drugs: 1) guided: 877; 2) unguided iCBT: 649; 3) drug: 324; waiting list: 0

  • Base-case analysis: ICER (calculated): 1) guided iCBT vs. waiting list: 300 per QALY; 2) unguided iCBT vs. waiting list: 1071 per QALY

Joesch et al, 2012,55 United States
  • Individual-level cost-effectiveness and cost–utility analysis

  • Parallel-group RCT, 17 clinics in 4 US cities (Arkansas, California, and Washington)

  • Health care payer perspective

  • Time horizon: 18 mo

  • Discount rate: 0%

  • Adults aged 18–75 yr, English- or Spanish-speaking, with an anxiety disorder (moderate anxiety) by DSM-IV (N = 690)

  • Mean age, iCBT vs. TAU: 44.7 (SD:12.8) vs. 45.6 (SD: 13.6) yr

  • Females, iCBT vs. control: 72% vs. 71%

  • 75%–78% had GAD, 62% with comorbid major depression at baseline; 57%–58% had more than 2 comorbid conditions 6 mo before baseline: 4 primary care visits and 1 ER visit, > 1 specialist visit

  • Intervention: guided iCBT modules (CALM) provided within a collaborative-care case-management model offered a choice of CBT, anti-anxiety medication, or both (n = 349)

  • Comparator: TAU (n = 341)

  • iCBT within collaborative care model: online CALM modules, 10–12 wk, supported by nonexpert care manager; care managers involved in care: assisted with treatment adherence, medication optimization, and consults with psychiatrists as needed; duration of treatment 3–12 mo, first course of 3 mo; if patient wanted, could repeat course up to 3 times at 3-mo intervals; after finishing treatment, 1-mo calls from managers reinforced CBT skills, drug adherence, or both

  • TAU: Usual care by GP, medication, counselling, or referral to a mental health specialist

  • Total QALYs (mean), iCBT vs. TAU, baseline to 18 mo: EQ-5D, 1.17 (95% CI 1.14–1.19) vs. 1.11 (1.09–1.14); SF-6D, 1.05 (95% CI 1.04–1.07) vs. 1.00 (0.98–1.02)

  • Mean difference, iCBT vs. TAU: EQ-5D, 0.05 (95% CI 0.01–0.09), SF-6D, 0.05 (95% CI 0.03–0.08)

  • Currency: USD Year: 2009

  • Total costs (mean), iCBT vs. TAU, baseline to 18 mo: 7,310.5 (95% CI 6,669–7,951) vs. 7,065.7 (95% CI 6,325–7,806)

  • Mean difference: 244.8 (95% CI −733 to 1,223)

  • Base-case analysis (complete case analysis, non-parametric, for EQ-5D), iCBT vs. TAU, INB > 0 at wtp of 5,000, 95% CI around INB > 0 at 60,000

  • Scenario analysis (missing data imputation analysis, non-parametric, for EQ-5D), iCBT vs. TAU, INB > 0 at wtp of 10,000, 95% CI around INB > 0 at 80,000

Hedman et al, 2011,58 Sweden
  • Individual-level cost–utility and cost-effectiveness analyses

  • Noninferiority parallel-group RCT

  • Societal perspective

  • Time horizon: 6 mo

  • Discount rate: 0%

  • Adults with SAD (N = 126)

  • Mean age, iCBT vs. group CBT: 35.2 (SD: 11.2) vs. 35.5 (SD: 11.6) yr

  • Females, iCBT vs. control: 37.5% vs. 33.9%

  • Anxiety present for around 20 yr, 16% with comorbid major depression; 34% of patients in iCBT and 38% of patients in group CBT received additional treatment (CBT, psychological treatment, or drugs) after finalizing the intervention in year 1

  • Intervention: guided iCBT modules including homework exercises (n = 64)

  • Comparator: face-to-face group CBT (n = 62)

  • iCBT: online modules, 15 wk, with access to a therapist (psychologist) and supportive email feedback via internet-based messaging system with no phone/face-to-face contact (10 min/wk); on average 9 of 15 modules completed, cost per treated patient was $464, and 5.5 min/wk of therapist's time

  • Group iCBT: 15 sessions, 1 individual and 14 weekly group CBT sessions including homework between sessions, 2.5 hr long, groups of 6–7 patients, led by CBT-trained experienced psychotherapists; on average 9 of 15 sessions completed, cost per treated patient was $2,687 and 50 min/wk of therapist's time

  • Total QALYs (mean), iCBT vs. group CBT, iCBT vs. group CBT, pre/post-treatment and 6 mo: before treatment, 0.77 (SD 0.18) vs. 0.74 (SD 0.19); 4 mo after treatment, 0.82 (SD: 0.14) vs. 0.80 (SD: 0.17); at 6 mo after treatment, 0.85 (SD: 0.14) vs. 0.81 (SD: 0.17)

  • Mean difference, iCBT vs. group CBT: 0.075

  • Currency: USD Year: 2009

  • Total costs (mean), iCBT, iCBT plus TAU, TAU (societal perspective): 9,457 (7,547–11,506) vs. 10,793 (8,412–13,328) vs. 11,244 (9,206–13,419) Total costs (mean), iCBT vs. group CBT, pre/post-treatment and 6 mo: before treatment, 7,048 (SD: 7,476) vs. 7,773 (SD: 7,926); 4 mo after treatment, $6,598 (SD: 7,337) vs. $8,648 (SD: 7,539); at 6 mo, $5,616 (SD: 7,456) vs. $7,650 (SD: 6,591)

  • Mean difference: –$1,335

  • Base-case analysis, iCBT vs. group CBT, ICER: −17,823 per QALY; cost saving and more effective

  • Probability of iCBT being cost-effective compared with group CBT at wtp of 0 per QALY is 81% and at wtp of >40,000 per QALY is 79%

  • Scenario analysis: costs of treatment only, iCBT vs. group CBT, ICER: −29,693 per QALY; cost saving and more effective

National Collaborating Centre for Mental Health and NICE, 2011,9 United Kingdom
  • Cost–utility analysis

  • Model-based analysis

  • NHS and PSS perspective

  • Time horizon: 12 mo

  • Discount rate: 0%

  • Adults with panic disorder (N = 21,000, 5% using iCBT of 425,000 patients in the UK)

  • Mean age: NR

  • Females: NR

  • 4 decision tree models: active panic-free status or not after treatment, remain panic-free or return to panic state at follow-up (52 wk); No utility data for specific health states panic disorder; utilities extrapolated from an ESEMeD study that measured utilities using EQ-5D in people with panic disorder for more than 12 mo and those without panic disorder: 0.76 (95% CI 0.70–0.82) and 0.91 (95% CI 0.90–0.91), respectively

  • Interventions: 1) Therapist-guided iCBT program “Panic Online”; 2) Guided iCBT “Internet Psykiatri”

  • Comparators: 1) TAU or 2) clinician-led CBT

  • iCBT: 12–14 wk, guided by a therapist (email messaging), follow-up at 52 weeks

  • Model 1: Panic Online vs. TAU; Model 2: Panic Online vs. clinician-led CBT; Model 3: Internet Psychiatri vs. waiting list; Model 4: Internet Psychiatri vs. clinician-led CBT

  • Total QALYs (mean per person), iCBT vs. control: 1) model 1: 85.46 vs. 80.79; 2) model 2: 83.059 vs. 83.29;3) model 3: 85.46 vs. 80.79; 4) model 4: 85.46 vs. 80.79

  • Mean difference: 1) model 1: 4.67; 2) model 2: −0.239; 3) model 3: 5.217;4) model 4: 1.25

  • Currency: £ Year: 2009

  • Total costs (mean), iCBT vs. control: 1) model 1: 59,429 vs. 23,933; 2) model 2: 91,756 vs. 61,456;3) model 3: 32,702 vs. 21,140;4) model 4: 26,217 vs. 69,567

  • Mean difference: 1) model 1: 35,496; 2) model 2: 30,300; 3) model 3: 11,562;4) model 4: 43,350

  • Intervention costs included therapist's costs, hardware (4 per person per computer), capital overheads (27 per person), license fee (none), server/website hosting costs (negligible)

  • Therapist's costs per patient based on time spent: 188–443, depending on model assumptions

  • Base-case analysis: ICER: 1) model 1: 7,599/QALY; 2) model 2: 126,849 (saving ∼130,000 for one QALY lost);3) model 3: 2,216/QALY;4) model 4: dominant

  • Probability of iCBT being cost-effective compared with control at wtp of 20,000 per QALY: 1) model 1: 92%; 2) model 2: 71%; 3) model 3: 85%; 4) model 4: 95%

Bergstrom et al, 2010,54 Sweden
  • Individual-level cost-effectiveness analysis

  • Single-blinded parallel-group RCT

  • Societal perspective

  • Time horizon: 6 mo

  • Discount rate: 0%

  • Adults with panic disorder (N = 113)

  • Mean age: NR

  • Females: NR

  • More than 50% were prescribed an antidepressant

  • Intervention: guided iCBT modules including homework exercises (n = 53)

  • Comparator: face-to-face group CBT (n = 60)

  • iCBT: 10 modules, 10 wk, with access to a therapist (psychologist) and supportive email feedback with no phone/face-to-face contact; on average 6.7 of 10 modules completed, and 35 min of therapist's time per patient (mean: 35.4 min, SD:19.6)

  • Group iCBT: 10 sessions, group CBT including homework between sessions, 2 hr long, led by 2 trained psychotherapists; on average 8 of 10 sessions completed, on average 6 hr of therapist's time per patient

  • Total response rate, iCBT vs. group CBT post-treatment: 60% vs. 63%

  • Mean difference, iCBT vs. group CBT: NR

  • Currency: € Year: NR

  • Total costs (mean), iCBT vs. group CBT, post-treatment: 86 vs. 325

  • Mean difference: 239

  • Therapist costs per patient/group, iCBT vs. group CBT, post-treatment: 21 vs. 260

  • Base-case analysis, iCBT vs. group CBT, ICER (calculated): 7,970 per responder; cost saving and less effective

  • Probability of iCBT being cost-saving (south-west quadrant) compared with group CBT: 62%

Titov et al, 2009,53 Australia
  • Individual-level cost-effectiveness analysis

  • Two RCTs

  • Health sector perspective

  • Time horizon: 6 mo

  • Discount rate: 0%

  • Adults aged 18 yr or older with social phobia, participants in Shyness 1 and Shyness 2 RCTs (N = 193)

  • Mean age: NR

  • Females: NR

  • Intervention: supported iCBT program “Shyness program” (n = 93)

  • Comparator: TAU: waitlist control (n = 100)

  • iCBT: 6 online sessions over 8–10 wk, supported by a clinical psychologist via email on regular basis, participation in online forum discussions and homework, completion rate: 79%

  • Total YLDs averted (calculated using the disability weight transfer factor for social phobia of 0.1876), iCBT vs. control: effect size of 1.07 × 0.1876 = 0.2007

  • Mean difference: 0.2007

  • Acceptability of iCBT explored at 6 mo: 44% who previously used face-to-face CBT for social phobia preferred using iCBT (reasons: anonymity)

  • Currency: AUD Year: 2008

  • Total costs (mean), iCBT vs. control: NR

  • Mean difference: 300

  • Costs of treatment: 3 hr of clinician time per patient (3 × 100/hr)

  • Base-case analysis: ICER: 1,495 per YLD averted

  • Sensitivity analysis, estimating costs of group CBT (800 per participant) vs. waiting list, ICER: 5,686 per YLD averted

McCrone et al, 2009,52 United Kingdom
  • Individual-level cost-effectiveness and cost–utility analysis

  • Pilot parallel group RCT

  • Undefined perspective

  • Time horizon: 6 wk

  • Discount rate: 0%

  • Adults with panic disorder (N = 90)

  • Mean age: 38 (SD: 13) yr

  • Females, iCBT vs. control: 69%

  • Intervention: iCBT modules “FearFighter” including homework (n = NR)

  • Comparator: 1) face-to-face CBT (n = NR), and 2) computer-aided relaxation (n = NR)

  • iCBT: 6 computer modules, self-guided, including homework; brief clinician in-person support at start and end of sessions (76 min over 10 wk)

  • Face-to-face CBT: 6 sessions, individual inperson, 1 hr, including homework; relaxation: 6 computer-guided sessions; brief clinician in-person support at start and end of sessions (76 min over 10 wk)

  • Total effects, iCBT vs. face-to-face CBT vs. relaxation, the mean improvement on the main problem ratings/global phobia rating: 3.95 vs. 3.93 vs. 0.71, P > .05/2.95 vs. 3.59 vs. 1.07, P > .05

  • Mean difference: NR

  • Currency: £ Year: NR

  • Total costs (mean), iCBT vs. face-to-face CBT vs. relaxation, assuming 196/patient: 281 (SD: 88) vs. 363 (SD: 158) vs. 110 (SD: 33)

  • Mean difference, iCBT vs. relaxation/iCBT vs. face-to-face: 90% CI, 143–£198/90% CI, −129 to −31

  • Costs not collected, but estimated on basis of UK guidelines: cost of FearFighter, 196/patient in one GP practice, 111/patient in primary care trust; CBT therapist costs: 69/hr; relaxation treatment cost, 0/patient

  • Base-case analysis: ICER, iCBT vs. relaxation/face-to-face vs. relaxation: 64–112 per point improvement/100–175 per point improvement

  • Probability of iCBT/face-to-face CBT being cost-effective compared with relaxation was 50% at a wtp of 100 per point improvement; for all values of wtp, iCBT had less chance to be cost-effective than face-to-face CBT

  • Cost-effectiveness of iCBT would be better if the salary of people supporting therapy was smaller (less well-trained clinicians)

Mihalopoulos et al, 2005,51 Australia
  • Cost-effectiveness analysis

  • Model-based analysis (using pilot RCT data)

  • Health sector perspective

  • Time horizon: 6 mo

  • Discount rate: 0%

  • Adults with panic disorder (NR, based on 2004 prevalence of panic disorder in Australia)

  • Mean age, iCBT vs. control: NR

  • Females, iCBT vs. control: NR

  • Interventions: 1) therapist-guided iCBT program “Panic Online”; 2) GP-assisted iCBT “Panic Online”

  • Comparator: face-to-face CBT by a GP or usual care (a mixture of no care/evidence-based principles and no-evidence-based medicine principles)

  • iCBT: 1) 12-wk intervention comprising iCBT plus 12 weekly 45-min sessions with a publicly funded psychologist, and one consultation with GP; 2) 12-wk iCBT plus 6 consultations with a GP

  • Total DALYs (mean), iCBT vs. usual care: NR

  • Mean difference: 870 DALYs (90% CI 540–1,200)

  • Assumed that effectiveness of iCBT is equal to effectiveness of face-to-face CBT

  • Currency: AUD Year: NR

  • Total costs (mean), iCBT by psychologist/iCBT by GP vs. usual care: NR

  • Mean difference, iCBT by psychologist/iCBT by GP vs. usual care: $3.8 million (90% CI, 2.3–5.3 million)/2.8 million (90% CI, $1.7–3.9 million)

  • Base-case analysis: ICER of iCBT by psychologist/by GP vs. usual care: 4,300/DALY averted/3,200/DALY averted

  • Probability of iCBT (by a psychologist or a GP) being cost-effective was 100% at wtp of 10,000

Kaltenthaler, 2006,50 United Kingdom
  • Cost–utility analysis

  • Model-based analysis

  • NHS perspective

  • Time horizon: 12 mo

  • Discount rate: 0%

  • Adult patients with panic disorder

  • Mean age, iCBT vs. control: NR

  • Females, iCBT vs. control: NR

  • Two-state Markov model with 3-mo cycle length (panic phobia or well); relapse rate (annual rate of 17%, 3-monthly rate of 0.045) assumed to be same for iCBT and face-to-face CBT; utilities assumed from ESEMeD study in patients with prior phobia: social phobia (0.79, 95% CI 0.75–0.84), agoraphobia (0.79, 95% CI 0.73–0.84) and specific phobia (0.82, 95%CI 0.80–0.85); well, no disorder (0.91, 95% CI 0.90–0.98)

  • Interventions, commercial pay-to-use programs (ST Solutions): FearFighter

  • Comparator: 1) iCBT for relaxation with brief coaching sessions of 5 min; 2) face-to-face CBT (6 hr of individual therapy)

  • iCBT: FearFighter (6-session module) with telephone support line

  • Total QALYs (mean), FearFighter vs. relaxation vs. face-to-face CBT: 0.794 vs. 0.736 vs. 0.805

  • Mean difference, FearFighter vs. relaxation/face-to-face CBT vs. FearFighter: 0.058/0.011

  • Currency: £ Year: NR

  • Total costs (mean), FearFighter vs. relaxation vs. face-to-face CBT: 217 vs. 78 vs. 410

  • Mean difference, FearFighter vs. relaxation/face-to-face CBT vs. FearFighter: 138/194

  • Base-case anaysis: FearFighter vs. relaxation/face-to-face CBT vs. FearFighter, ICER: 2,380 per QALY/17,608 per QALY

  • Probability of FearFighter vs. relaxation/face-to-face CBT vs. FearFighter at wtp 30,000 per QALY: 39%/61%

  • Reduction of the cost of FearFighter would lead to increase in the ICER (face-to-face CBT vs. FearFighter) and better acceptability of iCBT program as compared with face-to-face CBT

Abbreviations: CALM, Coordinated Anxiety Learning and Management; CBT, cognitive behavioural therapy; CCBT, computerized CBT; DALY, disability-adjusted life-year; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; EQ-5D, European Quality of Life questionnaire in five dimensions; ESEMeD, European Study of the Epidemiology of Mental Disorders; GAD, generalized anxiety disorder; GP, general practitioner; iCBT, internet-delivered cognitive behavioural therapy; ICER, incremental cost-effectiveness ratio; INB, incremental net benefit; NA, not applicable; NHS, National Health Service; NICE, National Institute of Health and Care Excellence; NR, not reported; PSS, personal social services PST, problem-solving therapy; QALY, quality-adjusted life-year; RCT, randomized controlled trial; ROI, return on investment; SAD, social anxiety disorder; SD, standard deviation; SF-6D, Short-Form Health Survey in 6 Dimensions; TAU, treatment as usual; wtp, willingness to pay; YLD, years lived with disability.